Indications
Treatment of human immunodeficiency virus (HIV-1)
Composition
- Active substance
- raltegravir potassium
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Raltegravir Viatris
- Active substance
- raltegravir potassium
- ATC code
- J05AJ01
- Therapeutic area
- HIV Infections
- Marketing authorisation holder
- Viatris Limited
- Status
- Application withdrawn
- EMA product number
- EMEA/H/C/005813